Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve This is to inform the exchange ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories has informed BSE that its Board of Directors will meet on Thursday, 31st July 2025 at 3:30 p.m. at its registered office in Mumbai. Key agenda items include approval of unaudited financial results for Q1 FY26 (quarter ended 30 June 2025), approval of the Director's Report for FY25, and approval of the Management Discussion & Analysis, Corporate Governance Report, and CEO's Certification. The Board will also consider reappointment of Mr. N.K. Menon as Whole Time Director & CEO for one year effective 1st October 2025, recommend appointment of Secretarial and Internal Auditors for FY26, and approve the draft notice of the forthcoming AGM. The trading window closure for designated persons will end two trading days after the board meeting, in line with insider trading norms.
This is a routine regulatory intimation ahead of the Q1 FY26 results announcement. Investors should watch for the actual financial results on/after 31st July 2025 for any meaningful stock price movement; the director reappointment items are standard governance matters.